More recently, a study reported that lenalidomide-resistant MM cells are capable of enhancing cell adhesion and EV production thus causing DR in sensitive MM cells, possibly being inhibited by the silence of SORT1 and LAMP2 genes associated with EV secretion [15]. The gene discussed is LAMP2; the disease is Miyoshi myopathy.